Connect with us

Cannabis News

Key Catalysts Look To Boost The Next Cannabis Stock Market Bull Run




This summer was a tough one for cannabis stocks. Market turmoil linked to global trade difficulties did not help and pot stocks faced many challenges with company scandals, regulatory issues, and a decline in investors. Some investors got caught up in the upswing without truly understanding the cannabis market. With Fall just around the corner, and with a reduction in bad execs and ignorant investors, those in the know should turn to solid companies who capitalize on a few key industry drivers. In terms of DC, Trump is indecisive when it comes to many things, but he is fairly motivated when it comes to making money. If he believes that loosening opposition to cannabis at the federal level to be an easy win in the 2020 election, he will likely support it. Companies that would benefit from a Trump-led initiative include Red White & Bloom, Curaleaf Holdings, and Trulieve Cannabis.

In Canada, branded consumables are part of legalization 2.0. Product innovation is picking up speed across the cannabis industry. Customers cannot wait to try the new varieties of edibles that are coming to market. The only concern with regards to edibles is the appeal to children. There is a lot of regulatory scrutiny as they become legalized and available in the market. Cannabis companies are not taking any risks and are controlling the distribution and labeling of edibles and other consumables. From an investor perspective, product innovation will also attract many traditional CPG investors who know how to recognize a successful market segmentation and sales approach.

Companies that stand to succeed with product innovation include Organigram Holdings, Aleafia Health Inc., Cronos Group, Canopy Growth, and Aurora Cannabis. These companies will now benefit from higher margins with previously approved flower, oil, and tincture products. Brick and Mortar stores are also gaining popularity. Cannabis consumers enjoy enjoy the experience of talking to experts and handling product. Canada which is advanced in regulations and facilitation of the cannabis industry is raffling off store licenses for physical retail. Online sales continue to be problematic even in the most liberal markets, so it is good news for listed Canadian companies to get shelf space.

The cannabis industry was quite tumultuous this summer and there was trouble at the top in many key companies ranging from Canopy’s firing of CEO Bruce Linton after disappointing earnings. CannTrust experienced serious Health Canada violations and Namaste’s public clash in the C-suite. Last year, Aphria also had its LATAM scandal in the media. Investors and boards voiced their concerns and replaced those needing replacement. There is hope that the recent purge and the new faces will lead to better decisions and less problems. Clarity in the US could also open the floodgates. There could be a leveling of federal and state regulation in the US that will allow Canadian operations to be brought to scale in the world’s largest economy.

Cheryl Anne hails from Great Britain and casts a large shadow with her master’s degree in Relationship Therapy as well as a number of other professional accreditations. While she specializes in psychological thrillers and self-help books, her undeniable and uncanny knack for sifting through the cracks of the cannabis and CBD space are extremely necessary and sought after.

Continue Reading

Ultimate CBD Guide


ultimate-cbd-products-company-guidepopular-cbd-health-benefits best-cannabidiol-guide-resources hemp guide

TimesofCBD is the most active daily CBD news publication featuring the latest cannabis industry stories and marijuana market trends. As the leader in CBD-centric content curation, we invite all readers to come for the headlines and stay for the insights. Quality is the top priority when presenting user guides, analyzing product reviews and reporting fact-checked news announcements. All information is for educational and informational purposes only. Disclaimer.

Got news? Email

Copyright © 2020 | Latest CBD News, Cannabis Guides and Marijuana Trends
Note: Always seek real additional medical advice and consultation with a professional healthcare practitioner before considering any CBD. No statements found on this website have underwent Food and Drug Administration evaluation. The efficacy of any products or claims made have never been approved by the FDA either. No products shall ever be intended to diagnose, treat or cure any disease or prevent any ailment.